Is the DEA Coming for the Hemp Industry After All?

On August 20, 2020, the United States Drug Enforcement Administration (“DEA”) issued an interim final rule (“IFR”) pertaining to the classifications of marijuana and hemp under the federal Controlled Substances Act (“CSA”) in light of the 2018 Agricultural Improvement Act (“AIA”). Because the DEA … Read more about Is the DEA Coming for the Hemp Industry After All?

DEA Removes CBD from Controlled Substances Act

On Monday, April 6, GW Pharmaceuticals revealed that the company had received notice from the U.S. Drug Enforcement Administration (“DEA”) stating that its drug Epidiolex was no longer subject to the requirements of the Controlled Substances Act (“CSA”). In a company release announcing the agency … Read more about DEA Removes CBD from Controlled Substances Act

DEA Announces Increased Access to Marijuana Research

On August 26, 2019, the United States Drug Enforcement Administration (“DEA”) issued a press release stating that DEA will be undertaking steps to increase access to DEA registrations required under federal law to cultivate and/or manufacture marijuana for research purposes. In making this … Read more about DEA Announces Increased Access to Marijuana Research

NIDA Announces Expansion of Cannabis Research

In an official statement issued earlier this month, the National Institute on Drug Abuse (“NIDA”) released a notice of special interest on public health research priorities with specific regard to cannabis. Published on August 14, NIDA’s announcement provides a written statement of purpose that … Read more about NIDA Announces Expansion of Cannabis Research

Revisiting the War on Drugs & Its Impact

July 14 marked the 50th anniversary of President Richard Nixon’s message to Congress asking for the establishment of a federal plan to tackle substance abuse, citing a dramatic increase in juvenile arrests for drug offenses. Nixon’s letter was the start of a new era of American drug policy as, the … Read more about Revisiting the War on Drugs & Its Impact

USDA Defends Interstate Transportation of Hemp

Earlier this week, the United States Department of Agriculture (“USDA”) issued a bulletin regarding the agency’s current view on hemp’s legality after the Agriculture Improvement Act of 2018 (“2018 Farm Bill”). In a memorandum to U.S. Secretary of Agriculture Sonny Perdue, USDA attorney Stephen … Read more about USDA Defends Interstate Transportation of Hemp

USPTO Issues Hemp Guidance

Earlier this month, the United States Patent and Trademark Office (“USPTO”) released an official examination guide in response to the Agricultural Improvement Act of 2018 (“2018 Farm Bill”) and associated applications. While the guide offers some clarity for the federal registration of trademarks … Read more about USPTO Issues Hemp Guidance

Psychedelic Medicine’s Rise in 2019

Late March of 2019, a collection of European technology investors made waves in the psychedelic medicine industry, amassing the largest-ever private financing round for biotech company, ATAI Life Sciences (“ATAI”). According to ATAI’s press release, the German-based company’s Series B financing … Read more about Psychedelic Medicine’s Rise in 2019